loading

Turnstone Biologics Corp Azioni (TSBX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-03-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - 19.31
Operating Expenses
15.88%
20.69
17.86 18.93 19.70
Operating Income/Loss
15.88%
-20.69
-17.86 -18.93 -0.394
Nonoperating Income/Loss
13.13%
1.078
1.241 1.578 0.38
Income/Loss From Continuing Operations Before Tax
18.04%
-19.61
-16.61 -17.35 0.068
Income Tax Expense/Benefit
109.70%
0.016
-0.165 -0.033 -0.082
Income/Loss From Continuing Operations After Tax
19.33%
-19.63
-16.45 -17.32 0.068
Net Income/Loss
19.33%
-19.63
-16.45 -17.32 0.068
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
500.48%
23.01
3.8322 17.40 -12.51
Diluted Average Shares
500.48%
23.01
3.8322 17.40 -12.51
Basic Earnings Per Share
454.17%
-0.85
0.24 -1.00 3.54
Diluted Earnings Per Share
454.17%
-0.85
0.24 -1.00 3.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):